Remdesivir Active Not Recruiting Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04501978ACTIV-3: Therapeutics for Inpatients With COVID-19
NCT04593940Immune Modulators for Treating COVID-19
NCT04610541REMdesivir-HU Clinical Study and Severe Covid-19 Patients